Co-Diagnostics, Inc. financial data

Symbol
CODX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4049 South Highland Drive, Salt Lake City, UT
State of incorporation
UT
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 736 % -51.5%
Quick Ratio 22.6 % -72.7%
Debt-to-equity 13 % +51.6%
Return On Equity -56 % -58.3%
Return On Assets -49.6 % -52.1%
Operating Margin -1.02K % -63.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.6M shares +7.4%
Common Stock, Shares, Outstanding 33.1M shares +5.74%
Entity Public Float 37M USD +12.1%
Common Stock, Value, Issued 37.9K USD +4.97%
Weighted Average Number of Shares Outstanding, Basic 30.3M shares +3.37%
Weighted Average Number of Shares Outstanding, Diluted 30.3M shares +3.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.92M USD -42.5%
Cost of Revenue 999K USD -76.1%
Research and Development Expense 21M USD -8.64%
Selling and Marketing Expense 4.48M USD -34.7%
General and Administrative Expense 16.2M USD +13.2%
Operating Income (Loss) -40.1M USD +6.15%
Nonoperating Income (Expense) 2.5M USD -45.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.6M USD +1.39%
Income Tax Expense (Benefit) 57.4K USD -100%
Net Income (Loss) Attributable to Parent -37.6M USD -6.53%
Earnings Per Share, Basic -1.24 USD/shares -3.33%
Earnings Per Share, Diluted -1.24 USD/shares -3.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.94M USD -80.3%
Marketable Securities, Current 26.8M USD -38.6%
Accounts Receivable, after Allowance for Credit Loss, Current 133K USD -56.4%
Inventory, Net 1.07M USD -35.6%
Assets, Current 32.3M USD -48%
Deferred Income Tax Assets, Net 4.27M USD
Property, Plant and Equipment, Net 2.76M USD -9.04%
Operating Lease, Right-of-Use Asset 2.11M USD -28.7%
Intangible Assets, Net (Excluding Goodwill) 26.1M USD -1.15%
Assets 64M USD -32.9%
Accounts Payable, Current 3.29M USD +122%
Accrued Liabilities, Current 2.56M USD +17.9%
Contract with Customer, Liability, Current 40.9K USD -88.7%
Liabilities, Current 7.32M USD +27.3%
Deferred Income Tax Liabilities, Net 203K USD -96.5%
Operating Lease, Liability, Noncurrent 1.24M USD -42.5%
Liabilities 9.69M USD +4.09%
Accumulated Other Comprehensive Income (Loss), Net of Tax 418K USD +185%
Retained Earnings (Accumulated Deficit) -33M USD -819%
Stockholders' Equity Attributable to Parent 54.3M USD -36.9%
Liabilities and Equity 64M USD -32.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.49M USD -43.5%
Net Cash Provided by (Used in) Financing Activities -482K USD -421%
Net Cash Provided by (Used in) Investing Activities 16.7M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 37.9M shares +4.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.18M USD
Deferred Tax Assets, Valuation Allowance 14.9M USD +115%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 22.1M USD +44.6%
Operating Lease, Liability 2.15M USD -28%
Payments to Acquire Property, Plant, and Equipment 402K USD +124%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.4M USD -5.32%
Lessee, Operating Lease, Liability, to be Paid 2.34M USD -29.9%
Operating Lease, Liability, Current 916K USD +9.21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 715K USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD +2.18%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -2.21M USD -62.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 190K USD -45.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 301K USD -57.9%
Deferred Tax Assets, Operating Loss Carryforwards 8.55M USD +112%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.2M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 308K USD +2.62%
Operating Lease, Payments 262K USD +38.9%
Additional Paid in Capital 102M USD +5.85%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 331K USD +4.61%
Deferred Tax Assets, Net of Valuation Allowance 7.19M USD -13.6%
Share-based Payment Arrangement, Expense 5.43M USD -34.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%